Association between hypertensive disorders of pregnancy and placenta accreta spectrum

Abstract Introduction Placenta accreta spectrum and hypertensive disorders of pregnancy are two significant contributors to severe maternal morbidity and fetal prematurity that may have related but opposite uteroplacental vascular origins. However, the relationship between these conditions is uncertain. Our aim was to evaluate the association between placenta accreta spectrum and hypertensive disorders of pregnancy while accounting for differences in the amount of time at risk for developing clinical manifestations of hypertensive disorders of pregnancy. Methods A cross‐sectional study using the National Inpatient Sample in the United States, 2017–2021. To reduce limitations of administrative coding for placenta accreta spectrum, the analysis was restricted to deliveries at <37 weeks’ gestation. Incidence rates and unadjusted incidence rate ratios were calculated, using gestational weeks to account for the person‐time‐at‐risk of developing hypertensive disorders of pregnancy. Multivariable Poisson regression models were used to examine the association between placenta accreta spectrum and hypertensive disorders of pregnancy after adjusting for confounding factors. Results Among 3,583,780 delivery hospitalizations between 2017 and 2021, 1,798,540 (unweighted n = 359,708) deliveries between ≥20 and <37 weeks were included. A total of 0.7% of individuals had placenta accreta spectrum, and 29.8% had hypertensive disorders of pregnancy. The incidence of hypertensive disorders of pregnancy significantly differed between those with and without placenta accreta spectrum (11.5 vs. 20.6 cases per 1000 person‐gestational weeks) with an unadjusted incidence rate ratio of 0.56 (95% confidence interval [CI] 0.51–0.61). After controlling for confounding factors, hypertensive disorders of pregnancy remained significantly lower in individuals with placenta accreta spectrum (adjusted incidence rate ratio 0.80, 95% CI 0.73–0.87). Conclusion Using a large, nationally representative dataset, hypertensive disorders of pregnancy had a significant inverse association with placenta accreta spectrum disorders.

Authors

Institutions

Publication Details

Journal
Pregnancy
Published
2025-05-01
DOI
https://doi.org/10.1002/pmf2.70030
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association between hypertensive disorders of pregnancy and placenta accreta spectrum

Nathan R. Blue, Amanda A. Allshouse, Michelle P. Debbink, Robert M. Silver et al.
Pregnancy
Pregnancy and preeclampsia studies
article

Association between hypertensive disorders of pregnancy and placenta accreta spectrum

Nathan R. Blue, Amanda A. Allshouse, Michelle P. Debbink, Robert M. Silver, Lauren H. Theilen, Matthew Givens, Brett D. Einerson
article en

Abstract

Abstract Introduction Placenta accreta spectrum and hypertensive disorders of pregnancy are two significant contributors to severe maternal morbidity and fetal prematurity that may have related but opposite uteroplacental vascular origins. However, the relationship between these conditions is uncertain. Our aim was to evaluate the association between placenta accreta spectrum and hypertensive disorders of pregnancy while accounting for differences in the amount of time at risk for developing clinical manifestations of hypertensive disorders of pregnancy. Methods A cross‐sectional study using the National Inpatient Sample in the United States, 2017–2021. To reduce limitations of administrative coding for placenta accreta spectrum, the analysis was restricted to deliveries at <37 weeks’ gestation. Incidence rates and unadjusted incidence rate ratios were calculated, using gestational weeks to account for the person‐time‐at‐risk of developing hypertensive disorders of pregnancy. Multivariable Poisson regression models were used to examine the association between placenta accreta spectrum and hypertensive disorders of pregnancy after adjusting for confounding factors. Results Among 3,583,780 delivery hospitalizations between 2017 and 2021, 1,798,540 (unweighted n = 359,708) deliveries between ≥20 and <37 weeks were included. A total of 0.7% of individuals had placenta accreta spectrum, and 29.8% had hypertensive disorders of pregnancy. The incidence of hypertensive disorders of pregnancy significantly differed between those with and without placenta accreta spectrum (11.5 vs. 20.6 cases per 1000 person‐gestational weeks) with an unadjusted incidence rate ratio of 0.56 (95% confidence interval [CI] 0.51–0.61). After controlling for confounding factors, hypertensive disorders of pregnancy remained significantly lower in individuals with placenta accreta spectrum (adjusted incidence rate ratio 0.80, 95% CI 0.73–0.87). Conclusion Using a large, nationally representative dataset, hypertensive disorders of pregnancy had a significant inverse association with placenta accreta spectrum disorders.

PregnancyVol. 1(3)
Intermountain Healthcare (US), University of Utah (US)
March of Dimes Foundation, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Openalex Percentile: Top 87%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.